Business Context and Reporting Period
Perspective Therapeutics, Inc. (NYSE American: CATX) filed a Current Report on Form 8-K on June 11, 2024, regarding a material corporate action. The report details the implementation of a one-for-10 reverse stock split of the Company's common stock, which became effective on June 14, 2024.
Key Financial Metrics
This filing is a current report regarding a capital structure change and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for these items.
Material Changes
- Reverse Stock Split: A one-for-10 reverse stock split was effected on June 14, 2024, at 4:01 p.m. Eastern Time.
- Share Count Adjustment: The number of issued and outstanding shares was reduced from approximately 674.3 million to approximately 67.4 million.
- Trading Status: Trading on the NYSE American resumed on a split-adjusted basis on June 17, 2024, under a new CUSIP number (46489V302).
- Fractional Shares: No fractional shares were issued; stockholders entitled to fractional shares received cash in lieu thereof based on the closing price on the effective date.
- Capital Structure: The total number of authorized shares and par values remained unchanged. Ownership percentages were preserved except for the cash-in-lieu adjustment.
- Derivatives: Outstanding options, warrants, and shares reserved for equity incentive plans were adjusted proportionally.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the reverse split and its timing. Management notes that these statements are subject to risks and uncertainties, including general market conditions. The Company explicitly states it undertakes no obligation to update these forward-looking statements. No specific financial guidance or operational outlook was provided in this document.
Investor Verification Checklist
- Verify the new CUSIP number (46489V302) for future trading and settlement.
- Confirm the adjusted number of shares held in brokerage accounts post-split.
- Check for cash payments received in lieu of fractional shares.
- Review the adjusted exercise prices and share quantities for any outstanding options or warrants.
- Monitor the stock price performance on the NYSE American following the June 17, 2024, resumption of trading.